TBAT Innovation Celebrates Their 20 Year Anniversary

TBAT Innovation Ltd are celebrating their 20th year of trading. To help celebrate the last 20 years, Founding Director, Sam Stephens has been reminiscing about how he began the company and the successes TBAT have had. In 2002, TBAT was established by Founding Director, Sam Stephens and 2 others. The company...

Charnwood Molecular Launches New Website

Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has launched a new website outlining in detail the company’s integrated drug discovery capabilities. The new site clearly sets out the company’s integrated drug discovery services along with its capabilities in bioscience, medicinal chemistry, computational...

Sygnature Discovery acquires Peak Proteins

Sygnature have acquired Peak Proteins Ltd. Following an extensive partnership between the two companies, this deal will enable seamless integration of protein production and related structure determination projects within Sygnature. Peak Proteins was set up in 2014 by scientists previously from AstraZeneca’s protein biochemistry and structural biology groups. Spearheaded by CEO, Mark Abbott, the...

Speakers confirmed for Medilink Midlands Innovation Day

Medilink Midlands Innovation Day is being held on Thursday, 12th May at The DoubleTree by Hilton, Coventry with around 180 delegates and exhibitors drawn from life science companies of all sizes and specialisms expected to attend. The event is sponsored by Coventry University. Medilink Midlands is a business support organisation...

Nottingham-based Cellomatics Biosciences wins Queen’s Award for Enterprise

Nottingham-based contract research organisation (CRO) Cellomatics Biosciences has today been recognised with one of the UK’s most prestigious business awards – the Queen’s Award for Enterprise for International Trade. Cellomatics is one of 225 organisations nationally to be recognised with a prestigious Queen’s Award for Enterprise. Employing 15 people, Cellomatics...

Upperton Pharma Solutions launches nasal delivery development platform

Nottingham-based contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions, has launched a unique nasal delivery development platform, UpperNose™, to make it easier and faster for small and mid-sized innovators to access the knowledge and capabilities necessary for the successful development of nasal dosage formulations. Drug developers seeking to evaluate...